Home Tags Dolasynthen

Tag: Dolasynthen

Mersana Presents Updated Data about its Dolasynthen Platform and Synthemer Scaffold

Clinical-stage bio-pharmaceutical company, Mersana Therapeutics, presented preclinical data from the company's proprietary Dolasynthen platform and its modular Synthemer scaffold during the 2019 Annual Meeting...

Mersana Therapeutics Focuses its Resources on Advancing XMT-1536, its First-in-Class ADC...

Mersana Therapeutics, a clinical-stage biopharmaceutical company developing a pipeline of antibody-drug conjugates or ADCs designed to target cancers in areas of high unmet need,...

DOWNLOAD